Evogene Ltd. (TLV:EVGN)
522.60
-2.30 (-0.44%)
Feb 20, 2025, 5:24 PM IDT
Evogene Revenue
Evogene had revenue of $1.80M USD in the quarter ending September 30, 2024, a decrease of -52.32%. This brings the company's revenue in the last twelve months to $7.48M, up 30.69% year-over-year. In the year 2023, Evogene had annual revenue of $5.64M with 236.72% growth.
Revenue (ttm)
$7.48M
Revenue Growth
+30.69%
P/S Ratio
0.98
Revenue / Employee
$52.66K
Employees
142
Market Cap
33.87M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
Dec 31, 2019 | 753.00K | -994.00K | -56.90% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 60.26B |
Danel (Adir Yeoshua) | 2.71B |
Kamada | 588.75M |
Bait Bakfar | 102.08M |
Novolog (Pharm-Up 1966) | 1.73B |
Ilex Medical | 982.96M |
BrainsWay | 143.60M |
SofWave Medical | 210.53M |
Evogene News
- 3 days ago - Evogene Schedules Fourth Quarter 2024 Financial Results Release - PRNewsWire
- 9 days ago - AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease - PRNewsWire
- 3 months ago - Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - GuruFocus
- 3 months ago - Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Evogene GAAP EPS of -$1.31 misses by $0.30, revenue of $1.8M misses by $1.05M - Seeking Alpha
- 3 months ago - Evogene Reports Third Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Evogene Q3 2024 Earnings Preview - Seeking Alpha
- 3 months ago - A Glimpse of Evogene's Earnings Potential - Benzinga